Patient-reported Outcome Measures in Patient Underwent Total Hip and Knee Arthroplasty
Launched by I.R.C.C.S OSPEDALE GALEAZZI-SANT'AMBROGIO · Jul 2, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how patients feel and function after having hip or knee replacement surgery, which is often done for conditions like osteoarthritis. Researchers at the Galeazzi Orthopedic Institute are collecting important information from patients, including their ability to use their joints and their overall health. They will use surveys to measure things like joint pain and satisfaction with the surgery, which will help improve future treatments.
To participate in this study, you need to be at least 18 years old and have undergone hip or knee arthroplasty, which is the medical term for joint replacement surgery. The trial is currently recruiting participants of all genders. If you join, you can expect to fill out questionnaires about how your joints are doing and how satisfied you are with your surgery. This information will help doctors understand the experiences of people who have had this surgery and improve care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • male and female
- • age more than 18
- • patient underwent hip or knee arthroplasty
- Exclusion Criteria:
- • age less than 18
- • comorbidity that can results in the difficulty to come back for the follow up
About I.R.C.C.S Ospedale Galeazzi Sant'ambrogio
The I.R.C.C.S. Ospedale Galeazzi-Sant'Ambrogio is a leading clinical research institute and hospital in Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As a designated Institute of Hospitalization and Care of Scientific Relevance (I.R.C.C.S.), it focuses on translational research that bridges the gap between laboratory findings and clinical applications. The facility is equipped with state-of-the-art technology and a multidisciplinary team of experts, enabling it to conduct a wide range of clinical trials aimed at improving treatment outcomes across various medical fields. Its dedication to ethical practices and patient safety ensures that all research activities align with the highest international standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milano, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials